Full text is available at the source.
Abstract
A cohort study examines the association between patient out-of-pocket costs and adherence to semaglutide treatment for obesity.
- Higher out-of-pocket costs may be linked to lower adherence rates in patients using semaglutide.
- The study focuses on commercially insured adults in the United States.
- Adherence to obesity treatment may vary significantly based on individual financial responsibilities.
Simplified
GLP-1 Therapies